Brain MRI atrophy quantification in MS: From methods to clinical application.
about
The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.'Timed up and go' and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis.Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.Anti lingo 1 (opicinumab) a new monoclonal antibody tested in relapsing remitting multiple sclerosis.Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.Is impaired information processing speed a matter of structural or functional damage in MS?
P2860
Brain MRI atrophy quantification in MS: From methods to clinical application.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Brain MRI atrophy quantification in MS: From methods to clinical application.
@ast
Brain MRI atrophy quantification in MS: From methods to clinical application.
@en
type
label
Brain MRI atrophy quantification in MS: From methods to clinical application.
@ast
Brain MRI atrophy quantification in MS: From methods to clinical application.
@en
prefLabel
Brain MRI atrophy quantification in MS: From methods to clinical application.
@ast
Brain MRI atrophy quantification in MS: From methods to clinical application.
@en
P2093
P2860
P50
P1433
P1476
Brain MRI atrophy quantification in MS: From methods to clinical application.
@en
P2093
Elisabetta Pagani
Jeroen J G Geurts
Marco Battaglini
Mark A Horsfield
Mark Jenkinson
Ralph H B Benedict
Roland G Henry
P2860
P304
P356
10.1212/WNL.0000000000003542
P407
P577
2016-12-16T00:00:00Z